OCS (Oculis Holding AG) Short-Term Capital Lease Obligation : $0.37 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Short-Term Capital Lease Obligation?

Oculis Holding AG's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.37 Mil.

Oculis Holding AG's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 ($0.20 Mil) to Mar. 2024 ($0.21 Mil) and increased from Mar. 2024 ($0.21 Mil) to Jun. 2024 ($0.37 Mil).

Oculis Holding AG's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($0.21 Mil) to Dec. 2022 ($0.15 Mil) but then increased from Dec. 2022 ($0.15 Mil) to Dec. 2023 ($0.20 Mil).

Oculis Holding AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Oculis Holding AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Short-Term Capital Lease Obligation Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.21

0.15

0.20

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial								0.20	0.20	0.20	0.21	0.37

Oculis Holding AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Oculis Holding AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.